What Mochi Health does

Mochi Health is a direct-to-consumer telehealth platform headquartered in San Francisco (SoMa), founded in 2022 by Myra Ahmad, M.D., that specializes in medication-based weight loss care and has expanded to more than 120 conditions spanning dermatology, hair loss, mental health, intimacy/sexual health, longevity, and menopause. The platform connects members to a 400+ board-certified provider network across obesity medicine, internal medicine, family medicine, pediatrics, OB/GYN, endocrinology, and bariatric surgery, plus registered dietitians, delivering care via 30-minute synchronous video visits, 24/7 asynchronous messaging, and prescriptions routed through affiliated state-licensed professional corporations (Mochi Medical, P.A. in Florida; Mochi Medical CA, P.C.; Mochi Medical NJ, P.C.; Mochi Medical KS, P.A.) that together enable telehealth coverage in all 50 U.S. states. The technology stack includes iOS and Android mobile applications, an AI-enabled EMR purpose-built for telehealth weight management, HIPAA-compliant infrastructure with BAA-backed business associate relationships, MFA access, automated breach detection, and Stripe-based payment processing; the company has also launched a two-sided Pharmacy Marketplace (January 2026) where licensed pharmacies and supplement suppliers onboard in under two minutes, list formulary, and receive auto-billing and weekly payouts.

Mochi's product set centers on GLP-1 medications: branded Wegovy and Zepbound, plus compounded semaglutide ($99/month) and compounded tirzepatide ($199/month) prescribed at provider discretion, alongside a Pediatrics program, a Wellness Plus insurance-eligible plan, and a standard "Health + Medication Plan" subscription. Distribution is direct-to-consumer through joinmochi.com and the mobile apps, with a self-serve eligibility quiz, a freemium tier, multi-month prepay options (1/3/6/12 months), and a $40-per-referral credit program; marketing is anchored on SEO/comparison content versus Ro/Hims/Hers, organic and paid social (Facebook, Instagram, LinkedIn, TikTok, X), email/newsletter, the Livelong Women's Health Summit, and earned media across Washington Post, Forbes, CNBC, WSJ, and NPR.

The business model blends three revenue streams: (1) recurring monthly subscription membership ($79/month list, $39 first-month promo, plus Wellness Plus at $69/month), (2) medication/transaction fees collected on behalf of partner pharmacies for compounded and branded GLP-1 fulfillment, and (3) marketplace listing and promotional fees charged to pharmacy and supplement partners. Per company disclosures, Mochi has served 500,000+ patients cumulatively and 100,000+ active members across the U.S., and recent strategic moves (the Pharmacy Marketplace launch, the December 2025 compounded GLP-1 product additions, the Eli Lilly lawsuit dismissal in October 2025, and the March 2026 women's-health vertical push) are oriented around deepening the platform moat while expanding beyond cash-pay weight loss. Notable risks include the February 2026 Washington state investigation into a Mochi-affiliated pharmacy and a reported June 2026 Tennessee patient hospitalization following a semaglutide overdose via a Mochi prescription, both of which are material category-level exposures for the compounded-GLP-1 core.

Name

Mochi Health

Legal name

Mochi Health Corp., Inc.

Website

http://joinmochi.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

101–250 employees

Short description

Mochi Health is a San Francisco-based direct-to-consumer telehealth platform specializing in medication-based weight loss care via branded and compounded GLP-1s, serving 500,000+ patients across all 50 U.S. states through a 400+ board-certified provider network, an AI-enabled EMR, and a 2026-launched pharmacy marketplace.

Ownership category

akta.pro rank

Product category

Telehealth weight loss services

NAICS

Home Health Care Services (62161), Home Health Care Services (621610), Offices of Other Health Practitioners (6213)

SIC

Services-Home Health Care Services (8082), Services-Health Services (8000)

akta.pro primary industry

Behavioral Health-Integrated Chronic Care (SUD comorbidity, collaborative care) (HLALAFAK)

akta.pro secondary industry

Medical Nutrition Therapy (Registered Dietitian) (HSADAFAE)

Keywords

• Telehealth weight loss
• Virtual clinical care
• GLP-1 prescriptions
• Online weight management
• Telehealth platform

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain

Revenue model

1. Monthly subscription membership: Recurring monthly membership fee paid by consumers ($79/month list, $39 promotional first month for new customers; multi-month prepaid plans at 3/6/12-month cadences; separate Wellness Plus plan at $69/month). Membership covers access to physicians, registered dietitians, in-app messaging, and 24/7 support. Free membership tier available.
2. Medication fees (prescription fulfillment): Separate Medication Fees collected by Mochi on behalf of partner pharmacies for prescription products, including branded GLP-1s (Wegovy, Zepbound) and compounded semaglutide ($99/mo) and tirzepatide ($199). Sold separately from membership via auto-refill medication subscriptions processed through Stripe.
3. Pharmacy Marketplace fees: Marketplace Fees charged to partner pharmacies and supplement suppliers for listing placement, promotional opportunities, and other optional features within the Mochi Marketplace.

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels7 records

Core offering

Mochi Health operates a direct-to-consumer telehealth platform that connects members with board-certified physicians, nurse practitioners, and registered dietitians for personalized weight loss and adjacent care (skincare, hair, mental health, longevity, menopause). Members complete an online eligibility questionnaire, subscribe to a monthly membership, attend live video visits, and receive doctor-prescribed treatments (including branded and compounded GLP-1 medications such as Wegovy, Zepbound, compounded semaglutide, and compounded tirzepatide) shipped to their door.

Product overview

Mochi Health operates a unified telehealth platform — branded as the Mochi Health Telehealth Platform — that combines a patient-facing care experience (web at joinmochi.com plus the Mochi Health Mobile App on iOS/Android) with a provider enablement offering (the Mochi Medical Provider Network) and a B2B Pharmacy Marketplace for licensed pharmacies and supplement suppliers. On top of this platform sit medication offerings (Compounded Tirzepatide, Compounded Semaglutide, branded Zepbound® and Wegovy®) and condition-specific sub-programs (the Pediatrics program and the Wellness Plus Plan insurance-eligible subscription tier). Care is delivered through board-certified physicians, nurse practitioners, and registered dietitians who use an AI-enabled EMR, with prescriptions routed to Mochi's affiliated medical practices (Mochi Medical P.A., Mochi Medical CA P.C., Mochi Medical KS P.A.) and dispensed through partner pharmacies listed in the Pharmacy Marketplace. The platform is offered via two subscription tiers — the standard Mochi Health Subscription (Health + Medication Plan) and the Wellness Plus Plan — both priced separately from medication costs.

Differentiator

Problem solved

Functional benefit

Products and services

• Mochi Health Telehealth Platform Virtual telehealth platform connecting members with board-certified doctors, registered dietitians, and care teams for weight loss, dermatology, hair, mental health, intimacy, and other health conditions, with personalized treatment pathways across 120+ conditions.
• Mochi Health Mobile App iOS and Android mobile application letting members choose a provider, browse medications for over 120 conditions, message providers anytime, and track progress.
• Compounded Tirzepatide Custom-compounded once-weekly subcutaneous tirzepatide injection prescribed at provider discretion as part of personalized weight loss plans; priced at $199/month for all doses.
• Compounded Semaglutide Custom-compounded oral semaglutide (GLP-1 receptor agonist) for daily oral administration as part of personalized weight loss plans; priced at $99/month for all doses.
• Zepbound (tirzepatide) FDA-approved once-weekly tirzepatide injection for chronic weight management and obesity-related obstructive sleep apnea, prescribed by Mochi providers.
• Wegovy (semaglutide) FDA-approved once-weekly semaglutide injection for chronic weight management and reduction of cardiovascular event risk in eligible adults, prescribed by Mochi providers.
• Mochi Pharmacy Marketplace Voluntary SaaS marketplace for licensed pharmacies and supplement suppliers to list medications, reach Mochi's patient/provider network, and access auto-billing, shipment, labeling, and inventory tools with weekly automatic payouts.
• Mochi Medical Provider Network B2B practice-enablement offering that gives licensed physicians and nurse practitioners an AI-enabled EMR, malpractice coverage, insurance contracts, admin/clinical support, and patient referrals at no cost to launch their practice.
• Mochi Pediatrics Program Specialized Mochi Health program for patients under 18, providing pediatric telehealth consultations, weight management care, and access to age-appropriate providers (parental/guardian consent required).

Named customers6 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature5 records

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Hims & Hers Health: Public direct-to-consumer telehealth company offering GLP-1 weight loss, hair, skin, mental health, and men's/women's health via subscription. Mochi explicitly compares itself against Hims/Hers on dedicated comparison pages and operates the same D2C subscription + tele-prescribing model.
• Ro: D2C telehealth platform offering weight care (including GLP-1s via Ro Pharmacy), men's health, women's health, dermatology, and smoking cessation. Mochi directly compares against Ro on its competitor pages and targets an overlapping consumer set with similar subscription/medication pricing.
• Found: Telehealth weight loss platform combining GLP-1 prescribing with behavioral coaching and registered dietitian support via subscription. Closely comparable to Mochi's core weight-care offering, including provider-led medication management and ongoing lifestyle support.
• Form Health: Telehealth obesity medicine practice providing board-certified physician-led care including GLP-1 prescribing and lifestyle support on a subscription basis. Directly comparable to Mochi in care delivery model, target patient, and pricing structure.
• Calibrate: Telehealth metabolic health platform combining GLP-1 medication with coaching and curriculum. Direct competitor in the same weight-loss subscription category and named in Mochi's competitive landscape.
• Henry Meds: Telehealth platform offering compounded semaglutide and tirzepatide for weight loss with provider consultations. Closely comparable to Mochi's compounded-GLP-1-led offering and pricing structure.
• Amble Health: Telehealth weight management platform prescribing GLP-1s with provider oversight; named alongside Mochi Health in the Tennessee semaglutide overdose adverse event report. Operates a near-identical tele-prescribing model for compounded and branded GLP-1s.

Broad incumbents

• Teladoc Health: Largest publicly-traded virtual care company offering telehealth across primary care, mental health, dermatology, and chronic condition management (including weight management via its BetterHelp and Livongo assets). Overlaps with Mochi across multiple condition verticals at much larger scale.
• PlushCare: Telehealth primary care provider offering online doctor visits, prescription services, and weight management support. Comparable to Mochi as a multi-condition D2C telehealth platform with subscription-like access, though broader in scope and not GLP-1-focused.
• K Health: AI-driven telehealth platform offering primary care, mental health, and weight management (including prescription support). Comparable to Mochi in multi-condition D2C tele-prescribing and app-based care delivery, with broader primary care positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/mochihealth
• Facebookfacebook.com/joinmochi
• LinkedInlinkedin.com/company/mochihealth
• Instagraminstagram.com/joinmochi
• TikToktiktok.com/@joinmochi

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries4 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mochi Health